Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- European Foundation for Study of Chronic Liver Failure
- Study ID
- NCT04613921
- Status
- Recruiting
Conditions
- Acute-On-Chronic Liver Failure
- Liver Cirrhosis
- Liver Diseases
- Liver Transplant; Complications
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Observational Protocol — OTHERThe cohorts will be followed for one year after LT transplantation except for group 3 (1-year follow-up after inclusion)
Study Details
Management of ACLF is mainly supportive. The poor outcomes lead physicians to consider liver transplantation as an option, even if controversial. In sicker recipients, LT results in immediate survival, but poor medium-term survival rates in some studies. The scarcity of deceased donors obliges to maximize LT success. Alternative strategies, as living-donor LT, should be explored. LDLT has impressive results in Eastern centers, but it is restrained in Western countries, due to potential life-threatening complications in the donor.
Key Dates
- Start date
- Jul 8, 2021
- Status verified
- Oct 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 3,000 participants (estimated)
Arms
- Arm: Group 1patients listed for liver transplantation with ACLF-2 or 3 at the time of listing or developing ACLF 2-3 while on the waiting list (n=2,000)
- Arm: Group 2patients listed for liver transplantation with decompensated cirrhosis without ACLF-2 or 3 and poor liver function (MELD \> 20) at the time of listing (n=500)
- Arm: Group 3patients having ACLF-2 or 3, are assessed for inclusion in the waiting list, but are finally not listed for liver transplantation (n=500)
Primary Outcome Measure
Survival [ Time Frame: 1 year ]
Central Contacts
- Anna Bosch34 93 227 1400
Locations (18)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cedars-Sinai Comprehensive Transplant Center | Los Angeles | California | 90048 | Alexander Kuo Alexander Kuo (PRINCIPAL_INVESTIGATOR) Nicholas Nissen (SUB_INVESTIGATOR) |
| University of Colorado | Aurora | Colorado | 80045 | Michael Kriss (PRINCIPAL_INVESTIGATOR) Elizabeth Pomfret (PRINCIPAL_INVESTIGATOR) |
| Tampa General Hospital | Tampa | Florida | 33606 | Nyingi Kemmer Ningi Kemmer (PRINCIPAL_INVESTIGATOR) |
| Piedmont Healthcare | Atlanta | Georgia | 30309 | Lance Stein Lance Stein (PRINCIPAL_INVESTIGATOR) Marwin Kazimi (SUB_INVESTIGATOR) |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | Justin R Boike (PRINCIPAL_INVESTIGATOR) Andrés Duarte (SUB_INVESTIGATOR) |
| The University of Chicago Medicine | Chicago | Illinois | 60637 | Helen Te |
| University of Maryland School of Medicine | Baltimore | Maryland | 21201 | Kirti Shetty (PRINCIPAL_INVESTIGATOR) John Lamattina (SUB_INVESTIGATOR) |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029-5674 | Ghideon Ezaz Ghideon Ezaz (PRINCIPAL_INVESTIGATOR) Chiara Rocha (SUB_INVESTIGATOR) |
| Montefiore Medical Center | New York | New York | 10467 | Brett Fortune (PRINCIPAL_INVESTIGATOR) Milan Kinkhabwala (SUB_INVESTIGATOR) |
| Weill Cornell Medicine | New York | New York | 10021 | Russell Rosenblatt (PRINCIPAL_INVESTIGATOR) Ben Samstein (SUB_INVESTIGATOR) |
| University of Cincinnati | Cincinnati | Ohio | 45219 | - |
| Cleveland Clinic | Cleveland | Ohio | 44195 | Bijan Eghtesad Bijan Eghtesad (PRINCIPAL_INVESTIGATOR) Christina Lindenmeyer (PRINCIPAL_INVESTIGATOR) |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | - |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Manhal Izzy (PRINCIPAL_INVESTIGATOR) |
| Baylor College of Medicine (Scott & White) | Dallas | Texas | 75246 | Amar Gupta Amar Gupta (PRINCIPAL_INVESTIGATOR) Robert Rahimi (PRINCIPAL_INVESTIGATOR) |
| Baylor St. Luke's Medical Centre | Houston | Texas | 77030 | Jalal Prasun Jalal Prasun (PRINCIPAL_INVESTIGATOR) |
| Michael E DeBakey VA Medical Center | Houston | Texas | 77030-4211 | Rubén Hernáez Rubén Hernáez (PRINCIPAL_INVESTIGATOR) |
| University of Utah Health | Salt Lake City | Utah | 84132 | Juan Gallego-Orozco (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
Related Studies
- DILIN - Prospective StudyRecruiting · Duke University · Los Angeles, California
- Physiologic and Functional Adaptations of Insulin Sensitive TissuesEnrolling By Invitation · Vanderbilt University Medical Center · Nashville, Tennessee
- Primary Sclerosing Cholangitis in ChildrenRecruiting · Arbor Research Collaborative for Health · Los Angeles, California
- Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver TransplantationEnrolling By Invitation · Johns Hopkins University · Baltimore, Maryland